{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:57:12Z","timestamp":1793145432745,"version":"4.5.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jaac.2021.07.009","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T21:00:08Z","timestamp":1626987608000},"page":"34-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Editorial: Safer Use of Antipsychotics in Youth (SUAY): Should Treatment Be Guided by Symptoms?"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9629-7827","authenticated-orcid":false,"given":"Gail A.","family":"Edelsohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3467-3807","authenticated-orcid":false,"given":"A. Reese","family":"Abright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2021.07.009_bib1","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003784","article-title":"National trends in off-label use of atypical antipsychotics in children and adolescents in the United States","volume":"95","author":"Sohn","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.jaac.2021.07.009_bib2","article-title":"Antipsychotic treatment among youths with attention-deficit\/hyperactivity disorder","volume":"2","author":"Sultan","year":"2019","journal-title":"JAMA Netw Open Psychiatry"},{"key":"10.1016\/j.jaac.2021.07.009_bib3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jaac.2019.01.015","volume":"58","author":"Jensen","year":"2019","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2021.07.009_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jaac.2020.12.026","article-title":"Editorial: Analyzing treatment and prescribing in large administrative datasets with a lens on equity","volume":"60","author":"Karnik","year":"2021","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2021.07.009_bib5","doi-asserted-by":"crossref","unstructured":"Findling RL, Zhou X, George P, Chappell PB. Diagnostic trends and prescription in disruptive mood dysregulation disorder and bipolar disorder. J Am Child Adolesc Psychiatry. Published online ahead of print June 3, 2021. https:\/\/doi.org\/10.1016\/j.jaac.2021.05.016","DOI":"10.1016\/j.jaac.2021.05.016"},{"key":"10.1016\/j.jaac.2021.07.009_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaac.2021.04.010","article-title":"Development of a symptom-focused model to guide the prescribing of antipsychotics in children and adolescents: Results of the first phase of the Safer Use of Antipsychotics (SUAY) clinical trial","volume":"61","author":"Penfold","year":"2021","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2021.07.009_bib7","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/1475-6773.12539","article-title":"Decrease in statewide antipsychotic prescribing after implementation of child and adolescent psychiatry consultation services","volume":"52","author":"Barclay","year":"2017","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jaac.2021.07.009_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1521\/capn.2016.21.6.1","article-title":"Deprescribing and its application to child psychiatry","volume":"21","author":"Bellonci","year":"2016","journal-title":"Child and Adolescent Psychopharmacology News"},{"key":"10.1016\/j.jaac.2021.07.009_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaac.2017.07.782","article-title":"Forward to the future: Clinical updates and clinical practice guidelines","volume":"56","author":"Walter","year":"2017","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856721004780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856721004780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:30:28Z","timestamp":1760193028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856721004780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0890856721004780"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2021.07.009","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial: Safer Use of Antipsychotics in Youth (SUAY): Should Treatment Be Guided by Symptoms?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2021.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2021.04.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a92021 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}